<DOC>
	<DOCNO>NCT03008044</DOCNO>
	<brief_summary>This single center prospective study . The purpose study assess performance FiberSense system across glucose measurement range ( hypoglycemia hyperglycemia ) compare gold standard reference laboratory method ( YSI glucose ) healthy volunteer .</brief_summary>
	<brief_title>Evaluation Percutaneous Optical Fibre Glucose Sensor ( FiberSense System )</brief_title>
	<detailed_description>The FiberSense system intend use diabetic patient home use set CGM system use interstitial fluid ( ISF ) glucose indicator blood glucose levels.The purpose study assess performance FiberSense system across glucose measurement range ( hypoglycemia hyperglycemia ) compare gold standard reference laboratory method ( YSI glucose ) healthy volunteer .</detailed_description>
	<criteria>Male female age ≥ 18 year old . Nondiabetic subject normal fast plasma glucose HbA1c ( ≤5.6 % ) Women pregnant , lactate plan pregnancy participation clinical study . Willingness , ability commitment comply test , procedure followup outline protocol include ( limited ) frequency clinic visit use prespecified glucose monitoring device . Willingness abstain bath swim participation measurement phase . In opinion investigator , absence physical limitation , addictive disease , underlie medical condition ( include mental health ) may preclude patient good study candidate . Written inform consent participate study provide patient . Currently pregnant , demonstrate positive pregnancy test screen day first sensor insertion Impaired hepatic function measure alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) ≥ three time upper reference limit . Impaired renal function measure serum creatinine &gt; 1.2 time upper limit normal . Any active acute chronic disease condition , opinion investigator , might interfere performance study . Any active acute chronic infectious disease , opinion investigator , would pose excessive risk study staff . Current use recent exposure medication opinion investigator could influence patient 's ability participate study performance test device . Extensive skin changes/diseases preclude wear require number device normal skin propose application site ( e.g. , extensive psoriasis , recent burn severe sunburn , extensive eczema , extensive scarring , extensive tattoo , dermatitis herpetiformis ) . Have know allergy medicalgrade adhesive , know hypersensitivity product use study . Known current recent alcohol drug abuse Blood donation 500 ml within last three month Currently participate another investigational study protocol test result may interfere study compliance , diagnostic result , data collection . History epilepsy History cardiac arrhythmia Clinically significant abnormality ECG screen An identify protect vulnerable patient ( include limit detention , prisoner ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>